Icflo DX Eye Drop is a sterile ophthalmic solution combining Ofloxacin 0.3% w/v, a broad-spectrum fluoroquinolone antibiotic, and Dexamethasone 0.1% w/v, a potent corticosteroid. This combination is indicated for the treatment of bacterial infections of the eye accompanied by inflammation. Ofloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and effectively eradicating susceptible pathogens. Dexamethasone exerts anti-inflammatory effects by suppressing the release of inflammatory mediators, reducing ocular redness, swelling, and discomfort. Icflo DX Eye Drop is commonly prescribed for bacterial conjunctivitis, keratitis, blepharitis, and other ocular surface infections where inflammation is prominent. The formulation ensures rapid penetration into ocular tissues, providing prompt relief and resolution of infection. It is essential to use this medication strictly under medical supervision, as inappropriate use may lead to fungal or viral superinfection or delayed healing. Patients should avoid contact lens use during treatment and adhere to the prescribed dosage regimen to minimize adverse effects such as increased intraocular pressure or hypersensitivity reactions. Icflo DX Eye Drop offers an effective therapeutic option by combining antimicrobial and anti-inflammatory actions to restore ocular health in infected and inflamed eyes.